Literature DB >> 872524

An investigation into the pathogenesis of hypertension in acromegaly.

M H Snow, D A Piercy, V Robson, R Wilkinson.   

Abstract

1. In 29 patients with acromegaly, plasma renin activity and growth hormone were measured during fasting and recumbency on free diet. Exchangeable sodium was measured in all cases and expressed as a percentage of the expected value on the basis of lean body mass. 2. Twenty-two control subjects without evidence of cardiovascular, renal or endocrine disease were studied in the same way. 3. There was a significant increase in exchangeable sodium and suppression of plasma renin activity in the acromegalic patients in comparison with control subjects. 4. There was a significant positive correlation between exchangeable sodium and plasma growth hormone. 5. Hypertensive acromegalic patients (diastolic blood pressure larger than or equal to 100 mmHg) tend to have a lower (although not significantly so) exchangeable sodium than normotensive subjects. 6. We conclude that (a) suppression of plasma renin activity in acromegaly can be explained by sodium retention, (b) hypersecretion of growth hormone is probably responsible for the increased exchangeable sodium, and (c) sodium overload cannot be directly related to blood pressure but may contribute to the increased occurrence of hypertension in acromegaly.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 872524     DOI: 10.1042/cs0530087

Source DB:  PubMed          Journal:  Clin Sci Mol Med        ISSN: 0301-0538


  5 in total

1.  Acromegaly and hypertension: prevalence and relationship to the renin-angiotensin-aldosterone system.

Authors:  C Kraatz; G Benker; F Weber; D Lüdecke; H Hirche; D Reinwein
Journal:  Klin Wochenschr       Date:  1990-06-19

2.  Generalised peripheral nerve dysfunction in acromegaly: a study by conventional and novel neurophysiological techniques.

Authors:  G A Jamal; D J Kerr; A R McLellan; A I Weir; D L Davies
Journal:  J Neurol Neurosurg Psychiatry       Date:  1987-07       Impact factor: 10.154

3.  Cardiac function in endocrine diseases: I. Acromegaly.

Authors:  R Griebenow; L Krämer; U Frangenberg; B Allolio; D Kaulen; F Saborowski; W Winkelmann
Journal:  Klin Wochenschr       Date:  1989-11-17

4.  Plasma renin activity and urinary aldosterone in acromegaly.

Authors:  F Mantero; G Opocher; D Armanini; G Paviotti; M Boscaro; M Muggeo
Journal:  J Endocrinol Invest       Date:  1979 Jan-Mar       Impact factor: 4.256

5.  Altered dopaminergic modulation of sympathetic nervous system activity in idiopathic edema.

Authors:  R A Catania; J R Sowers; N Stern; M L Tuck; J Paris
Journal:  J Endocrinol Invest       Date:  1984-10       Impact factor: 4.256

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.